NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland - Royal DSM, a global purpose-led science-based company active in Health, Nutrition and Bioscience, today began construction of a new manufacturing facility at its site in Dalry, Scotland - DSM.com
DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland

 

NewswireTODAY - /newswire/ - Heerlen, Netherlands, 2022/11/30 - Royal DSM, a global purpose-led science-based company active in Health, Nutrition and Bioscience, today began construction of a new manufacturing facility at its site in Dalry, Scotland - DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The plant will significantly increase global production of Bovaer®, DSM’s unique methane-reducing feed additive for cattle. In an official groundbreaking ceremony attended by the First Minister of Scotland, Nicola Sturgeon, and Dimitri de Vreeze, Co-CEO of DSM, the company marked the next step in its plan to use Bovaer® to reduce global methane emissions and contribute to worldwide methane reduction targets. 

DSM announced that planning had started during the UN Climate Change Conference last year in Glasgow. Construction officially began today on a facility that will help DSM scale-up production of Bovaer® in the coming years and marks another milestone in the company’s ambition to bring its methane-reducing feed additive to the market worldwide. This development of DSM’s Dalry site has been supported by the Scottish Government through Scottish Enterprise, the national agency supporting economic development and innovation.

Reducing methane emissions is crucial for keeping warming below the 1.5°C target outlined in the Paris Agreement. Over 100 countries have signed a Global Methane Pledge, agreeing to reduce global methane emissions by at least 30% by 2030. The addition of new signatories in recent months, such as Australia in October 2022, underscores growing recognition of the need for urgent action. Ruminants (mainly cows) emit around 20% of all methane gasses globally, so reducing emissions in ruminant herds will play a vital role in meeting global climate ambitions.

Bovaer® is a feed additive that can achieve an average enteric methane reduction of 30% in dairy cows, and 45% in beef cattle (with some tests showing reductions of up to 90%). DSM has initial product volumes available for near term market development. The product is in the early commercialization phase in many countries around the world, including the EU/EEA, Argentina, Australia, Brazil, Chile, Pakistan, Switzerland, Turkey, and Uruguay. Since the start of the development of Bovaer® an estimate of 15,000 tons of CO2e has been saved, and reductions will accelerate further once the Dalry plant is fully operational, expected in the course of 2025.

Rt Hon Nicola Sturgeon MSP, First Minister of Scotland, said: “Just one year on from the announcement at COP26, I am very pleased to see the progress being made on site and the fact that spades are now in the ground.

We are here today to celebrate a world-leading project and multi-million pound investment which will make Scotland the home of this innovative product, underlining that Scotland continues to lead the way in delivering a net zero future.” 

Dimitri de Vreeze, Co-CEO of DSM, commented: “After many years of hard work and dedication, it’s a wonderful feeling to attend the groundbreaking ceremony for such a large-scale production facility. This is a historic moment for DSM: We are continuing to deliver on our 2030 methane pledge, one of our food systems commitments. I wish the construction team every success as they develop this plant in the coming years.”

Scottish Enterprise’s Chief Executive, Adrian Gillespie, added: “Today’s groundbreaking ceremony is a significant milestone and the next step in delivering such an innovative project for Ayrshire and Scotland.

Royal DSM’s Project Bovaer® has the potential to be a game-changer for emissions reductions from cattle. Scottish Enterprise has developed a close relationship with Royal DSM over many years and we were delighted to work with the company to secure Dalry as the home for this global manufacturing opportunity.” 

About Bovaer®

Bovaer® is a feed additive for cows researched and developed over 10 years by DSM. Just a quarter teaspoon of Bovaer® per cow per day consistently reduces enteric methane emission by on average 30% for dairy cows on average 45% for beef cattle. The feed additive Bovaer® therefore contributes to a significant and immediate reduction of the environmental footprint of meat, milk and dairy products. Bovaer® is the most extensively studied and scientifically proven solution to the challenge of burped methane to date. Upon feeding, it takes effect immediately.

About DSM in Dalry

DSM is one of the region’s most prominent companies, employing over 400 staff and around 150 to 200 contractors at the Dalry production facility situated in North Ayrshire, 25 miles south-west of Glasgow. The site has been producing vitamins since 1958 and today the main production processes are Vitamin C, Calcium-D-Pantothenate (vitamin B5) and Panthenol (proVitamin B5). 

All our vitamin forms produced at the Dalry facility serve the highly varied needs of the human and animal nutrition and health sectors, as well as the pharmaceutical industry and personal care industries.

The Dalry site is fully committed to sustainability for the future. We have delivered significant investment to demonstrate continued reduction of our CO₂ emissions, which has focused on technology improvements within our production processes and utilities operations. This work continues to identify further continuous improvement activity alongside development of step change opportunities.

Contact: Dave Huizing - DSM Investor Relations
P: +31 45 578 2864 - E: investor.relations[.]dsm.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Bovaer | Royal DSM
Contact: Mirelle van der Kreeft - DSM.com 
+31 45 578 2420 media.contacts[.]dsm.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
SCHOTT Pharma Offers Complete Testing Suite for Container Selection and Drug Submission Preparation
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
Ipsen’s Onivyde® Regimen, A Potential New Standard-of-care First-line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
Frost & Sullivan and Trautec have Conducted An Extensive Investigation Across the Recombinant Type XVII Collagen Industry Chain
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Bushu Pharma Recognized with Frost & Sullivan’s 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award
BASF Pharma Solutions and IFF Pharma Solutions Establish Collaboration on Virtual Pharma Assistant Platform ZoomLab™

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)